Sitemap > News > Infectious Diseases
Displaying 1 - 50 of 555 results
- Cervarix, the GSK cervical cancer candidate vaccine, provides sustained immune response in 100 per cent of women up to 55 years of age
- Human Genome Sciences Announces Positive Final Results of Phase 2b Trial of Albuferon
- XTL PROVIDES UPDATE ON PHASE I CLINICAL TRIAL OF XTL-2125
- KaloBios Initiates a U.S. Phase 1 Study of Its Second Drug Candidate, KB001
- Valopicitabine Combined With Standard of Care Cleared Hepatitis C Virus in 72% of Patients Who Completed 12 Weeks of Treatment In A Phase II Trial
- Vertex Reports 2007 Pipeline Progress
- ViroPharma Announces Completion of Enrollment in 500mg BID Arms of HCV-796 Phase 2 Study
- Boehringer Ingelheim initiates SPRING study of Aptivus (tipranavir) in diverse group of highly treatment-experienced HIV-positive patients
- Boehringer Ingelheim initiates SPRING study of Aptivus (tipranavir) in diverse group of highly treatment-experienced HIV-positive patients
- Pharmasset Presents Clevudine and Racivir Data at the International HIV Drug Resistance Workshop
- Novartis gains European approval for its innovative flu vaccine Optaflu
- US FDA Grants Orphan Drug Status to Immtech
- BIOCRYST PRESENTS PHASE I PERAMIVIR DATA AT THE OPTIONS FOR THE CONTROL OF INFLUENZA CONFERENCE
- Phase I for Influenza vaccine adjuvanted with Intercell’s IC31 started
- Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL
- Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
- Immtech Completes Dosing Protocol of Malaria Prevention Trial
- Pfizer Receives Approvable Letter From FDA For Maraviroc
- Theravance Announces Enrollment of Last Patient in Phase 3 Hospital-Acquired Pneumonia Clinical Program with Investigational Antibiotic, Telavancin
- First Ad35-Based HIV-1 Vaccine Enters Phase I Clinical Trial at NIH
- Arpida receives approval from US FDA to initiate a Phase II trial with iclaprim in hospital-acquired, ventilator- and healthcare-associated pneumonia
- PEGINTRON(TM) and REBETOL(R) Combination Therapy Approved in European Union for Treating Hepatitis C in Patients Coinfected With HIV
- Second Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
- Alnylam Initiates Phase II Clinical Trial to Evaluate Safety and Anti-viral Efficacy of ALN-RSV01 in the Treatment of Respiratory Syncytial Virus (RSV) Infection
- Hemispherx Biopharma Initiates Phase IIb Trial in Australia for Ampligen as Vaccine Adjuvant for Seasonal Influenza
- Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
- Dynavax Starts HEPLISAV(TM) Phase 3 in Europe; U.S. Study; and Phase 2 in ESRD in Canada
- Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839
- SciClone Initiates Phase 2 Clinical Trial Using SCV-07 to Treat Hepatitis C Patients
- FDA Priority Review Granted for ISENTRESS™ (raltegravir), Merck's Investigational Integrase Inhibitor for HIV
- Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
- Ceragenix(TM) Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
- MEDIVIR ANNOUNCES BRISTOL-MYERS SQUIBB HAS TERMINATED THEIR AGREEMENT FOR THE DEVELOPMENT OF MEDIVIR'S PRECLINICAL POLYMERASE INHIBITOR, MIV-170
- ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
- Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
- NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
- Theravance Announces Positive Results from Phase 2 Clinical Study with Investigational Antibiotic in Patients with Complicated Skin and Skin Structure Infections
- DEPOMED ANNOUNCES RESULTS OF PHASE 3 CLINICAL TRIAL FOR GABAPENTIN GR(TM) IN POSTHERPETIC NEURALGIA
- Peregrine Pharmaceuticals Initiates Bavituximab Clinical Trial in HCV Patients Co-Infected With HIV
- Vical Reaches Initial Enrollment Milestone in Phase 2 Trial of DNA Vaccine Against CMV
- Pharmasset and Roche Initiate Studies to Advance R7128 for HCV
- Abbott Announces Approval of First Fully-Automated Blood Screening Test for Hepatitis C Antibodies
- Valopicitabine Development Program Placed on Clinical Hold in the United States
- First child vaccinated with Intercell JE Vaccine in India - Pediatric Phase II trial started
- Acambis' universal influenza vaccine enters Phase 1 trial
- ARPIDA REPORTS POSITIVE RESULTS OF SECOND PIVOTAL PHASE III TRIAL WITH INTRAVENOUS ICLAPRIM IN CSSSI
- Neurochem receives approvable letter for eprodisate (KIACTA) for treatment of AA amyloidosis
- GeoVax Annouces Start of 2 New HIV/AIDS Vaccine Human Trials
- Metabasis Therapeutics Announces CS-917 Phase 2b Clinical Trial Results and Reports on Status of Pradefovir
- Mpex Pharmaceuticals Initiates Multi-dose Clinical Trial in the U.S. with MP-376 in Patients with Cystic Fibrosis